- Report
- October 2025
- 120 Pages
Global
From €5344EUR$5,950USD£4,565GBP
- Report
- November 2025
- 119 Pages
Global
From €3500EUR$4,174USD£3,094GBP
- Report
- November 2025
- 120 Pages
Middle East
From €5344EUR$5,950USD£4,565GBP
- Report
- April 2026
- 402 Pages
Global
From €4446EUR$4,950USD£3,798GBP
- Report
- March 2026
- 304 Pages
Global
From €2245EUR$2,500USD£1,918GBP
- Report
- October 2025
- 150 Pages
Global
From €5344EUR$5,950USD£4,565GBP
- Report
- May 2026
- 140 Pages
Global
From €2694EUR$2,999USD£2,301GBP
€3592EUR$3,999USD£3,068GBP
- Report
- April 2026
- 146 Pages
Global
From €2694EUR$2,999USD£2,301GBP
€3592EUR$3,999USD£3,068GBP
- Report
- June 2026
- 195 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- July 2026
- 196 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- July 2026
- 198 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- June 2026
- 190 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- January 2026
- 187 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- January 2026
- 181 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- January 2026
- 188 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- August 2026
- 188 Pages
Global
From €5254EUR$5,850USD£4,488GBP

Imaging biomarkers are a type of biomarker used to measure and monitor biological processes in the body. They are used to detect and diagnose diseases, assess the effectiveness of treatments, and monitor the progression of diseases. Imaging biomarkers are typically used in conjunction with other biomarkers, such as genetic and molecular biomarkers, to provide a more comprehensive picture of a patient's health. Imaging biomarkers can be used to detect changes in the structure and function of organs, tissues, and cells. Examples of imaging biomarkers include MRI, CT, PET, and ultrasound.
Imaging biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and radiology. They are also used in clinical trials to assess the safety and efficacy of new treatments. Imaging biomarkers are becoming increasingly important in the diagnosis and treatment of diseases, as they provide a more detailed picture of a patient's health.
Companies in the imaging biomarker market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, and Hitachi Medical Systems. Show Less Read more